Literature DB >> 32655237

Do Recipients of Genetically Related Donors Have Better Outcomes After Living Donor Liver Transplantation?

Narendra S Choudhary1, Sujeet K Saha1, Sanjiv Saigal1, Dheeraj Gautam2, Neeraj Saraf1, Amit Rastogi1, Prashant Bhangui1, Srinivasan Thiagrajan1, Arvinder S Soin1.   

Abstract

BACKGROUND: There are few data on genetic relation of the donor and outcomes in living donor liver transplantation (LDLT) recipients. We compared outcomes of LDLT between recipients of genetically related and unrelated donors in a large single-center series.
METHODS: The study included 1372 adult, ABO-compatible, primary LDLT recipients, who received a graft from either a first-degree relative (parent, sibling, son, or daughter; n = 756) or unrelated donor (spouse or relative of the spouse; n = 616).
RESULTS: The mean age of the recipients with a related donor was 50.2 ± 10.8 years compared with 47.3 ± 9.3 years for recipients with unrelated donors (P = 0.000). Chronic rejection was significantly more common in the genetically unrelated donor group than in the genetically related donor group (28 [4.5%] versus 9 [1.1%]; P = 0.000) at a mean follow-up of 37 months (15-95 months). There were no significant differences in other outcomes between the 2 groups. The 12-month and 36-month survival between the unrelated and related groups was 87.6% versus 90%, and 86.3% versus 89.7% respectively (P = 0.115). The multivariate analysis revealed genetically unrelated donors (odds ratio [OR]: 3.88, 95% confidence interval [CI]: 1.80-8.34, P = 0.001) and history of acute cellular rejection (OR: 3.39, 95% CI: 1.68-6.81, P = 0.001) as predictors of chronic rejection.
CONCLUSION: Although chronic rejection was found to be more common in genetically unrelated donors, the patient survival after LDLT was similar.
© 2019 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACR, acute cellular rejection; CMV, cytomegalovirus; HLA, human leukocyte antigen; LDLT, living donor liver transplantation; acute rejection; chronic rejection; liver transplantation; living donor; survival

Year:  2019        PMID: 32655237      PMCID: PMC7335709          DOI: 10.1016/j.jceh.2019.12.004

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  19 in total

1.  Impact of HLA matching upon outcome after liver transplantation.

Authors:  Ulf P Neumann; J M Langrehr; Martina Lang; V Schmitz; S Menzel; T Steinmueller; P Neuhaus
Journal:  Transplant Proc       Date:  2002-08       Impact factor: 1.066

Review 2.  Impact of human leukocyte antigen mismatching on outcomes of liver transplantation: a meta-analysis.

Authors:  Xiang Lan; Ming-Man Zhang; Cong-Lun Pu; Chun-Bao Guo; Quan Kang; Ying-Chun Li; Xiao-Ke Dai; Yu-Hua Deng; Qiang Xiong; Zhi-Mei Ren
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

3.  Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients.

Authors:  Lawrence U Liu; Carol A Bodian; Gabriel E Gondolesi; Myron E Schwartz; Sukru Emre; Sasan Roayaie; Thomas D Schiano
Journal:  Transplantation       Date:  2005-10-27       Impact factor: 4.939

4.  Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years.

Authors:  A Jain; A J Demetris; R Kashyap; K Blakomer; K Ruppert; A Khan; S Rohal; T E Starzl; J J Fung
Journal:  Liver Transpl       Date:  2001-07       Impact factor: 5.799

5.  A large, single center investigation of the immunogenetic factors affecting liver transplantation.

Authors:  T J Doran; A F Geczy; D Painter; G McCaughan; A G Sheil; C Süsal; G Opelz
Journal:  Transplantation       Date:  2000-04-15       Impact factor: 4.939

6.  [Comparison of acute cellular rejection between living donor liver transplantation and cadaveric liver transplantation].

Authors:  S Fan; Z Zhang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2001-09-25

7.  HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.

Authors:  Po-Chang Lee; Lan Zhu; Paul I Terasaki; Matthew J Everly
Journal:  Transplantation       Date:  2009-08-27       Impact factor: 4.939

8.  Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.

Authors:  S Simona Jakab; Victor J Navarro; Beth W Colombe; Constantine Daskalakis; Steven K Herrine; Simona Rossi
Journal:  Liver Transpl       Date:  2007-10       Impact factor: 5.799

9.  De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.

Authors:  H Kaneku; J G O'Leary; N Banuelos; L W Jennings; B M Susskind; G B Klintmalm; P I Terasaki
Journal:  Am J Transplant       Date:  2013-06       Impact factor: 8.086

10.  Impact of donor-recipient genetic relationship on outcome of living donor liver transplantation.

Authors:  Mahmoud Abdelwahab Ali; Mohamed Morsi Elshobari; Tarek Salah; Al-Refaey Kandeel; Ahmad Mohammad Sultan; Ahmad Nabieh Elghawalby; Ahmed Shehta; Usama Elsayed; Omar Fathy; Amr Yassen; Mohamed Abdel Wahab
Journal:  Liver Transpl       Date:  2017-01       Impact factor: 5.799

View more
  1 in total

Review 1.  Liver Transplant Outcomes in India.

Authors:  Narendra S Choudhary; Prashant Bhangui; Arvinder S Soin
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-01-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.